Location History:
- Chadds Ford, PA (US) (1976)
- Kennett Square, PA (US) (1978 - 1996)
Company Filing History:
13 out of 16,338 
6 out of 206 Years Active: 1976-1996
Title: Engelbert Ciganek: Innovator in Psychotropic Drug Development
Introduction
Engelbert Ciganek, based in Kennett Square, PA, is a renowned inventor with a remarkable portfolio that boasts 19 patents. His work focuses primarily on the development of novel psychotropic drugs, particularly those targeting sigma receptors. Ciganek's innovations have significant implications for treating conditions such as drug-induced psychosis and dyskinesia.
Latest Patents
One of Ciganek's recent patents pertains to (N-phthalimidoalkyl)piperidines. This invention describes novel (N-phthalimidoalkyl) piperidine compounds that exhibit selective sigma-receptor antagonism, making them potentially effective for treating physiological or drug-induced psychosis and dyskinesia in mammals. The patent also elaborates on pharmaceutical compositions that contain these sigma-selective compounds, along with methods for their use in medical treatments.
Another significant patent involves hydroisoindolines and hydroisoquinolines as psychotropic drugs. Ciganek's research into these novel nitrogen-containing bicyclic compounds reveals their utility in treating similar psychotropic conditions. These compounds have been identified as selective sigma-receptor antagonists with a low potential for movement disorder side effects, offering an advantage over typical antipsychotic agents.
Career Highlights
Ciganek has had a notable career, predominantly within prominent companies such as E.I. DuPont de Nemours and Company and the DuPont Merck Pharmaceutical Company. His professional journey reflects a commitment to pharmaceutical innovation, particularly in the field of mental health.
Collaborations
Throughout his career, Ciganek has had the privilege of collaborating with esteemed colleagues, including Ashokkumar Bhikkappa Shenvi and Leonard Cook. These partnerships have undoubtedly contributed to the success of his inventions and further advanced the field of psychotropic drug development.
Conclusion
Engelbert Ciganek stands out as an influential figure in the realm of pharmaceutical invention. His dedication to developing innovative compounds for treating serious mental health issues has resulted in significant contributions to the industry. With a robust patent portfolio and collaborative efforts with other experts, Ciganek continues to pave the way for future advancements in psychotropic treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.